Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. - Rudd,R.M.; Gower,N.H.; Spiro,S.G. (J Clin Oncol, 2005)